Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dental pulp mesenchymal stem cells for limb-girdle muscular dystrophy
IRCT20140911019125N13Phase 2Recruiting
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dental pulp mesenchymal stem cells in limb-girdle muscular dystrophy (LGMD), sponsored by Kerman University of Medical Sciences. Primary endpoints: Clinical symptoms and Electromyography. Started Apr 2025; status: recruiting.
02
Drugs
dental pulp mesenchymal stem cells
03
Conditions
limb-girdle muscular dystrophy (LGMD)
Beyond the preview
Go deeper on IRCT20140911019125N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140911019125N13.